Meh. It wouldn't surprise me if these trials are being run by the makers of Remdesivir or some other drug, and they're purposely killing folks to make their treatment look more effective. It's a pretty common tactic in the pharma industry for drug makers to do trials with enormous doses of their competitors products to make them look more dangerous by comparison, and given that this whole thing has turned into a multi-billion dollar cash grab I would assume that that's what's happening here unless proven otherwise.
It's the same thing with famatodine, where someone observed that folks taking it for heartburn have a lower risk of death. So rather than doing an RCT with giving folks 10mg orally (a normal dose), someone started doing an RCT with like 140mg injected.
Just thinking about it logically, why would you ever give someone a drug that ostensibly works by blocking viral replication when they've already had the virus for multiple weeks? It makes zero sense, which tells you there is something shady going on.